BB
Bonus Biogroup Ltd.
BBIXF · OTC
$0.03 -25.00% (-$0.01)
1M +0.00%
Market Cap 106.8M ₪
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.03
0.0% downside
Current Price
$0.03
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BBIXF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/FFO N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
Book val. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
0 /100
Poor ROIC 734.63%
ROA 158.60%
Asset turnover 0.00x
Debt
0 /100
High Current ratio 0.13x
Int. coverage -58.37x
Debt/Equity N/A
Stability
58 /100
Moderate Beta 0.79x
EPS volatility 40.88%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BBIXF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Shai Meretzki
Employees
42
Headquarters
Haifa